{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:47:05Z","timestamp":1793119625666,"version":"4.5.0"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.2169\/internalmedicine.5369-25","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T18:08:47Z","timestamp":1751479727000},"page":"134-138","source":"Crossref","is-referenced-by-count":2,"title":["Linear Mucosal Defect in Nintedanib-associated Colitis: A Rare Case with Collagenous Colitis-like Features"],"prefix":"10.2169","volume":"65","author":[{"given":"Keisuke","family":"Iwata","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Gifu Prefectural General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gifu Prefectural General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Kushima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shiga University of Medical Science, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gifu Prefectural General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gifu Prefectural General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gifu Prefectural General Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Gifu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370: 2071-2082, 2014.","DOI":"10.1056\/NEJMoa1402584"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Oda K, Matsunaga T, Sennari K, Yatera K. Colitis associated with nintedanib therapy for idiopathic pulmonary fibrosis (IPF). Intern Med 56: 1267-1268, 2017.","DOI":"10.2169\/internalmedicine.56.8065"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Amini A, Koury E, Chahla E. Nintedanib-induced colitis treated effectively with budesonide. Cureus 12: e9489, 2020.","DOI":"10.7759\/cureus.9489"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sejben A, Sejben I, Budai A, et al. Inflammatory bowel disease- mimicking colitis associated with nintedanib-based therapy in a lung cancer patient. Int J Surg Pathol 31: 1326-1328, 2023.","DOI":"10.1177\/10668969221143472"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Odah T, Karime C, Hashash JG, Farraye FA. Nintedanib-induced colitis can mimic inflammatory bowel disease. ACG Case Rep J 11: e01282, 2024.","DOI":"10.14309\/crj.0000000000001282"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miyaguchi K, Tsuzuki Y, Uemuara H, et al. Nintedanib-associated enterocolitis with intractable diarrhea: a case report. Clin J Gastroenterol 17: 271-275, 2024.","DOI":"10.1007\/s12328-023-01894-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Makino M, Kawaguchi K. Colitis with subepithelial hyaline fibrosis associated with nintedanib therapy for fibrosing interstitial lung disease: a drug-related collagenous colitis? Pathol Int 74: 663-665, 2024.","DOI":"10.1111\/pin.13484"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Masclee GM, Coloma PM, Kuipers EJ, Sturkenboom MC. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol 110: 749-759, 2015.","DOI":"10.1038\/ajg.2015.119"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wollin L, Maillet I, Quesniaux V, Holweg A, Ryffel B. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther 349: 209-220, 2014.","DOI":"10.1124\/jpet.113.208223"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Umeno J, Matsumoto T, Nakamura S, et al. Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis. Gastrointest Endosc 67: 1185-1191, 2008.","DOI":"10.1016\/j.gie.2008.02.013"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kato M, Sasaki S, Nakamura T, et al. Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis. Sci Rep 9: 12062, 2019.","DOI":"10.1038\/s41598-019-48593-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wind S, Schmid U, Freiwald M, et al. Clinical pharmacokinetics and pharmacodynamics of nintedanib. Clin Pharmacokinet 58: 1131-1147, 2019.","DOI":"10.1007\/s40262-019-00766-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chandler RE. Nintedanib and ischemic colitis: signal assessment with the integrated use of two types of real-world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health-care databases. Pharmacoepidemiol Drug Saf 29: 951-957, 2020.","DOI":"10.1002\/pds.5022"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Khalili H, Axelrad JE, Roelstraete B, Ol\u00e9n O, D&apos;Amato M, Ludvigsson JF. Gastrointestinal infection and risk of microscopic colitis: a nationwide case-control study in Sweden. Gastroenterology 160: 1599-1607, 2021.","DOI":"10.1053\/j.gastro.2021.01.004"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5369-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:26:12Z","timestamp":1767410772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5369-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5369-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"5369-25"}}